Carmichael Hill & Associates »

Seelos Therapeutics shares owned by Carmichael Hill & Associates

Quarter-by-quarter ownership of Seelos Therapeutics shares owned by Carmichael Hill & Associates from 13F filings

Historical chart of Carmichael Hill & Associates investment in Seelos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics held by Carmichael Hill & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics by Carmichael Hill & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $233 62 3.76

More positions owned by Carmichael Hill & Associates

Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Berkshire Hathaway Inc Del Call Call Option (Principal) (BRK.B)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard World Inf Tech Etf (VGT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Ser Tr S&p Divid Etf (SDY)
Vanguard Index Fds Small Cp Etf (VB)
Alphabet Call Call Option (Principal) (GOOGL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Whitehall Fds High Div Yld (VYM)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)

View all positions for Carmichael Hill & Associates

Top funds holding Seelos Therapeutics

Modera Wealth Management
BlackRock
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co
Group One Trading
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group

View all funds holding Seelos Therapeutics